6303 related articles for article (PubMed ID: 3283252)
1. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
3. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
4. [Expression of HLA-class II antigens in malignant melanoma].
Nakamura T; Matsuno M; Kageshita T; Arao T
Nihon Hifuka Gakkai Zasshi; 1990 Jan; 100(1):49-56. PubMed ID: 2191157
[TBL] [Abstract][Full Text] [Related]
5. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
9. Differential tissue distribution of HLA-DR, -DP and -DQ antigens.
Forsum U; Claesson K; Jonsson R; Karlsson-Parra A; Klareskog L; Scheynius A; Tjernlund U
Adv Exp Med Biol; 1987; 216A():233-9. PubMed ID: 3687525
[No Abstract] [Full Text] [Related]
10. Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases.
Matsuoka T; Tabata H; Matsushita S
J Immunol; 2001 Feb; 166(4):2202-8. PubMed ID: 11160273
[TBL] [Abstract][Full Text] [Related]
11. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
[TBL] [Abstract][Full Text] [Related]
15. The role of HLA class II antigens in the induction of cytotoxic T lymphocytes.
Demesová V; Buc M; Ferencík S; Sasazuki T; Shawkatová I; Porubská S
Eur J Immunogenet; 1995 Dec; 22(6):425-34. PubMed ID: 8597559
[TBL] [Abstract][Full Text] [Related]
16. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
[TBL] [Abstract][Full Text] [Related]
17. Gamma interferon induces detectable serological and functional expression of DR and DP but not DQ antigens on cultured amniotic fluid cells.
Maurer DH; Callaway C; Sorkin S; Pollack MS
Tissue Antigens; 1988 Apr; 31(4):174-82. PubMed ID: 3136555
[TBL] [Abstract][Full Text] [Related]
18. Detection of antibodies specific for HLA-A,B,C,DR,DQ and DP by the erythrocyte antibody rosette inhibition (EAI) and immune phagocytosis inhibition (IPI) tests.
Faust A; Neppert J
J Immunol Methods; 1987 Aug; 102(1):71-5. PubMed ID: 3476673
[TBL] [Abstract][Full Text] [Related]
19. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.
Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S
J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553
[TBL] [Abstract][Full Text] [Related]
20. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
